Gynecology & Obstetrics
Open Access
ISSN: 2161-0932
ISSN: 2161-0932
Birhanu Jikamo Bago
Introduction: Operative delivery is defined as any procedures carry out to facilitate the delivery of the infant. Globally in, 2010, an estimated 18.5 million Cesarean Section (CS) are carry out each year. In Ethiopia, large proportion of the population be lacking in access to essential obstetric care including CS.
Objective: The aim of this study was to determine the prevalence and its associated factors among women undergone operative delivery at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia, 2017.
Methods and materials: This study conducted in Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia from June to August, 2017. Retrospective record review study was conducted over the past three year’s period from June 2014-June 2016 G.C. Mothers who gave birth over the past three years were the study population. A systematic random sampling technique was used to recruit the study participants. The sample size was determined using a single population proportion formula and a total of 414 study participants were used. Logistic regression was carried out to identify factors associated with women undergone operative delivery. Adjusted odds ratios with their 95% confidence intervals and p<0.05 were considered to have significant association.
Results: In the current study overall prevalence of operative delivery was 38.4% [95% CI: 0.34, 0.43]. Among these; 35.4% were cesarean section, vacuum 2.10%, and Forceps 0.9% deliveries respectively. The probability of operative delivery was 67% [AOR=1.67; 95%CI: 1.05, 2.66] and & 5.31 times [AOR=5.31; 95%CI: 1.79, 5.69] more likely to practice operative delivery in the age group of 25-34 year and >=35 years than 15-24 years.
Conclusions and recommendations: Significant proportion of women practiced operative delivery. Age of women, gestational age and antepartum hemorrhage were main factors with women undergone operative delivery. Emphasis needs to be given women in the group of 25-34 and >=35 years.